Current Status and Future of Multidisciplinary Team in Hepatocellular Carcinoma by Jinbin CHEN, Yaojun ZHANG, Minshan CHEN

Get full text

Risk-averse Robust Interval Economic Dispatch for Power Systems with Large-scale Wind Power Integration by Zhenjia Lin, Haoyong Chen, Jinbin Chen, Jianping Huang, Mengshi Li

Get full text

Association between combined urinary phthalate metabolites exposure and grip strength among residents in Guangzhou, China by Jinbin Chen, Jie Shi, Guojun Xu, Guojun Xu, Wenru Feng, Jiayun Lv, Tongxing Shi, Qinqin Jiang, Qinqin Jiang

Get full text

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy by Fei Cao, Fei Cao, Fei Cao, Fei Cao, Chunyong Wen, Chunyong Wen, Chunyong Wen, Chunyong Wen, Yujia Wang, Yujia Wang, Yujia Wang, Yujia Wang, Hongtong Tan, Hongtong Tan, Hongtong Tan, Hongtong Tan, Shaohuan Hao, Jinbin Chen, Jinbin Chen, Jinbin Chen, Jinbin Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Lujun Shen, Lujun Shen, Lujun Shen, Lujun Shen, Lin Xie, Lin Xie, Lin Xie, Lin Xie, Han Qi, Han Qi, Han Qi, Han Qi, Tao Huang, Tao Huang, Tao Huang, Tao Huang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Zilin Huang, Zilin Huang, Zilin Huang, Zilin Huang

Get full text

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Weijie Wu, Weijie Wu, Weijie Wu, Zhiwen Hu, Zhiwen Hu, Zhiwen Hu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zili Hu, Zili Hu, Zili Hu, Yangxun Pan, Yangxun Pan, Yangxun Pan, Juncheng Wang, Juncheng Wang, Juncheng Wang, Jinbin Chen, Jinbin Chen, Jinbin Chen, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Minshan Chen, Minshan Chen, Minshan Chen, Dandan Hu, Dandan Hu, Dandan Hu

Get full text

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment by Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen

Get full text